Anlon Healthcare delivered exceptional financial performance in the quarter ended June 2026, with consolidated net profit rising 87.61% to ₹6.66 crore compared to ₹3.55 crore in the corresponding quarter of the previous year. According to reports from Business Standard, this significant profit growth demonstrates the company's strong operational performance during the quarter.
The company's sales revenue surged 162.94% to ₹87.56 crore in Q1 FY2026, as reported by Business Standard. This substantial revenue growth indicates robust business expansion and market demand for the company's products or services during the quarter.
Operating profit margin (OPM) improved to 17.80% in the June 2026 quarter from 18.74% in the corresponding quarter of the previous year, as reported by Business Standard. The company's PBDT (Profit Before Depreciation and Tax) increased 171% to ₹14.73 crore and PBT (Profit Before Tax) rose 173% to ₹13.66 crore during the quarter.
According to the financial data reported by Business Standard, the company's performance shows significant improvement across all key metrics compared to the same quarter in the previous financial year. The substantial growth in both profit and revenue indicates strong operational efficiency and market positioning during the quarter.
